https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-142014-11-01 00:00:002019-02-15 08:46:20Perspectives for immunotherapy in glioblastoma treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-702014-11-01 00:00:002019-02-15 08:47:43Emerging treatment strategies for glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:912014-11-01 00:00:002014-11-01 00:00:00Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-31 / Oncoimmunology 2015 Aug;4(8):e970462
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-31 / Oncoimmunology 2015 Aug;4(8):e9704622014-10-31 00:00:002019-02-15 08:45:09Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e0024
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e00242014-10-29 00:00:002019-02-15 08:39:37Dendritic cell cancer vaccines: from the bench to the bedside
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-502014-10-21 00:00:002014-10-21 00:00:00Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-18 / Expert Opin Biol Ther 2015 Jan;15(1):79-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-18 / Expert Opin Biol Ther 2015 Jan;15(1):79-942014-10-18 00:00:002019-02-15 08:47:21Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-322014-10-15 00:00:002019-02-15 09:18:18Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-15 / Mol Med Rep 2015 Jan;11(1):317-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-15 / Mol Med Rep 2015 Jan;11(1):317-262014-10-15 00:00:002014-10-15 00:00:00Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-07 / Semin. Oncol. 2014 Dec;41(6):714-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-07 / Semin. Oncol. 2014 Dec;41(6):714-292014-10-07 00:00:002019-02-15 09:17:06Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care
